<p>Concomitant Mutations in EGFR 19Del/L858R Mutation and Their Association with Response to EGFR-TKIs in NSCLC Patients</p>-Reference-Cited by-同舟云学术

Concomitant Mutations in EGFR 19Del/L858R Mutation and Their Association with Response to EGFR-TKIs in NSCLC Patients

Published:2020-09 Issue: Volume:Volume 12 Page:8653-8662
ISSN:1179-1322
Container-title:Cancer Management and Research
language:en
Short-container-title:CMAR

Author:

Liang Hengrui,Li Caichen^ORCID,Zhao Yi,Zhao Shen,Huang Jun,Cai Xiuyu,Cheng Bo,Xiong Shan,Li Jianfu,Wang Wei,Zhu Changbin,Li Weiwei,He Jianxing,Liang Wenhua

Publisher

Informa UK Limited

Subject

Oncology

Reference30 articles.

1. EGFR Mutations and Lung Cancer

2. Treatment approaches for EGFR-inhibitor-resistant patients with non-small-cell lung cancer

3. The impact of epidermal growth factor receptor mutations on the prognosis of resected non-small cell lung cancer: a meta-analysis of literatures

4. Efficacy and safety of first line treatments for patients with advanced epidermal growth factor receptor mutated, non-small cell lung cancer: systematic review and network meta-analysis

5. Targeting non-small cell lung cancer with small-molecule EGFR tyrosine kinase inhibitors

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination of microwave ablation and systemic treatments achieve a long survival time for a patient with metachronous advanced double primary lung and colon adenocarcinoma: A case report;Oncology Letters;2024-06-28

2. Exploring the Cause of Survival Disparities in EGFR-Mutated Lung Cancer Subtypes: Unraveling Distinctive Genomic and Phenotypic Features of 19Del and L858R Mutation Subtypes;Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry;2024-06

3. MET overexpression correlated with prognosis of EGFR-mutant treatment‑naïve advanced lung adenocarcinoma: a real‑world retrospective study;Clinical and Translational Oncology;2024-03-02

4. Primary versus acquired epidermal growth factor receptor Thr790Met mutant non-small cell lung cancer: clinical features and prognoses;Clinical and Translational Oncology;2024-01-08

5. Tissue and Plasma-Based Highly Sensitive Blocker Displacement Amplicon Nanopore Sequencing for <i>EGFR</i> Mutations in Lung Cancer;Cancer Research and Treatment;2023-11-20